Biofarm S.A. Logo

Biofarm S.A.

A top domestic manufacturer of pharmaceuticals, supplements, and soft gelatin capsules.

BIO | RO

Overview

Corporate Details

ISIN(s):
ROBIOFACNOR9
LEI:
254900G63HUEZ1Z9UW08
Country:
Romania
Address:
LOGOFĂTUL TĂUTU, 031212 BUCUREȘTI, SECTORUL 3
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1921, Biofarm S.A. is a manufacturer of pharmaceuticals and food supplements. The company is a significant producer of soft gelatin capsules and ranks among the top drug manufacturers in its domestic market. Its portfolio includes over 200 products covering approximately 61 therapeutic areas, such as nutritional supplements, vitamins, and dermatological drugs. Biofarm distributes its products through national partners and also engages in export activities. With over a century of history, the company is a long-standing presence in the pharmaceutical sector.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 14:54
Board/Management Information
Schimbari in conducerea societatii comerciale - RC09
English 103.6 KB
2025-11-04 14:53
Board/Management Information
Schimbari in conducerea societatii comerciale - RC09
Romanian 97.2 KB
2025-11-03 15:26
Post-Annual General Meeting Information
Hotararea consiliului de administratie / organe abilitate (in conformitate cu p…
English 160.6 KB
2025-11-03 15:25
Post-Annual General Meeting Information
Hotararea consiliului de administratie / organe abilitate (in conformitate cu p…
Romanian 163.8 KB
2025-10-31 15:28
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
English 130.4 KB
2025-10-31 15:27
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
Romanian 133.3 KB
2025-09-24 15:23
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
English 248.0 KB
2025-09-24 15:22
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 219.8 KB
2025-09-24 15:20
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
English 119.8 KB
2025-09-24 15:19
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
Romanian 108.5 KB
2025-08-14 17:44
Interim Report
Raport Financiar Semestrial - RFS
Romanian 4.0 MB
2025-08-08 15:30
Notice of Dividend Amount
Plata dividend - RC17
English 200.1 KB
2025-08-08 15:29
Notice of Dividend Amount
Plata dividend - RC17
Romanian 224.9 KB
2025-06-25 11:52
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
English 131.4 KB
2025-06-25 11:50
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
Romanian 116.7 KB

Automate Your Workflow. Get a real-time feed of all Biofarm S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Biofarm S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Biofarm S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BRIGHT MINDS BIOSCIENCES INC. Logo
Developing next-gen serotonergic drugs for neurological and psychiatric disorders like epilepsy.
United States of America DRUG
BRISTOL MYERS SQUIBB CO Logo
Develops innovative medicines for oncology, immunology, and cardiovascular diseases.
United States of America BMY
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea 003000
Burning Rock Biotech Ltd Logo
Offers NGS-based diagnostics for precision oncology, from detection to clinical trial support.
United States of America BNR
C4 Therapeutics, Inc. Logo
Developing protein degrader medicines to treat cancer and other serious diseases.
United States of America CCCC
Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for a curative reset in autoimmune diseases.
United States of America CABA
Cadrenal Therapeutics, Inc. Logo
Developing novel anticoagulant therapies for high-risk cardiovascular patients.
United States of America CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.
United States of America CALC
Calidi Biotherapeutics, Inc. Logo
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
United States of America CLDI
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden CALTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.